The webinar will update on latest developments in MALDI mass spectrometry for high-throughput screening and CPD profiling (rapifleX MALDI PharmaPulse) and introduce Bruker's new surface plasmon resonance (SPR) instrument, the SIERRA SPR-32. Beside technical details explaining the latest developments, synergies between MALDI mass spectrometry and SPR will be discussed.
Dr. Meike Hamester
Director Small Molecule Pharma Business
Senior Application Specialist, Bruker Daltonics SPR
For Research Use Only. Not for use in clinical diagnostic procedures.